Catalyst
Slingshot members are tracking this event:
PharmaMar (PHM.MC) Expects CHMP Recommendation in H2 for Aplidin in Multiple Myeloma
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PHM.MC |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 09, 2017
Occurred Source:
https://www.pharmamar.com/wp-content/uploads/2017/08/PR_Quadruple-combination_Aplidin.pdf
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Chmp, Recommendation, Aplidin, Multiple Myeloma, European Comission
